Jordan Dunitz, MD

Professor of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine

Jordan Dunitz

Contact Info

Mailing Address:
420 Delaware Street SE
MMC 276
Minneapolis, MN 55455

Administrative Assistant Name

Administrative Phone

Administrative Email

Administrative Fax Number

Professor of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine

Director, Minnesota Cystic Fibrosis Center and Adult CF Program

Medical Director, Center for Lung Science and Health Clinic

Pulmonologist and Critical Care Physician

Medical School, SUNY Stony Brook Health Sciences Center School of Medicine, Stony Brook, NY

Residency, University of Minnesota, Minneapolis, MN

Fellowship, University of Minnesota, Minneapolis, MN


My main clinical interests are cystic fibrosis (CF) and lung transplantation. I developed and direct the University of Minnesota Adult CF Program and am Director of our CF Center. In addition to CF, I am interested in the management of other bronchiectatic lung disease including Primary Ciliary Dyskinesia. I am involved in the pre-transplant evaluation and post-transplant management of patients referred for lung transplantation for both CF and other end-stage lung disease. My involvement in lung transplantation has led me to develop expertise in interventional bronchoscopy for both transplant-related and non-transplant airway disease. I am experienced in balloon dilation, and stent placement. In the in-patient arena I mainly focus on CF and lung transplantation, but also participate in general pulmonary consultation and all aspects of intensive care management. In addition to my direct patient care responsibilities, I participate actively in continuous clinical quality improvement activities in the Adult CF Program.

Awards & Recognition

  • Mpls St. Paul Magazine "Top Doctor" (2012-2015)
  • Best Doctors in America® (2011-2012, 2013)


Research Summary/Interests

I have served as site Primary Investigator for a number of phase II and III trials for new medications for CF patients, including VX-770 and Denfosol. I have participated as a co-investigator for numerous other phase I-III trials for new CF and transplant medications as well.

I have also participated as a primary or co-investigator for a number of investigator-initiated clinical studies. I am an active participant in a number of collaborative studies at the University of MN CF Center, related to cystic fibrosis and lung transplantation.




  • Pulmonology


Center for Lung Science and Health;Transplant Center

Clinical Interests

Cystic fibrosis; Lung transplantation; Primary ciliary dyskinesia; Bronchiectasis; Interventional bronchoscopy